Voltage-gated potassium channels Kv3.2, Kv3.4, and Shaker-related (Kv1) (Kv3.2/Kv3.4/Kv1)

Voltage-gated potassium channels Kv3.2 (KCNC2), Kv3.4 (KCNC4), and Shaker-related (Kv1) channels are essential membrane proteins that regulate potassium ion flux in response to membrane potential changes. Kv3.2 and Kv3.4 belong to the Shaw-related family and are distinguished by their high activation thresholds and rapid deactivation kinetics, which enable neurons to fire at high frequencies (Rudy & McBain, 2001). The Shaker-related family (Kv1) typically operates at lower voltage thresholds and is crucial for determining the resting membrane potential and action potential duration (Gutman et al., 2005). Dysregulation of these channels is implicated in several neurological conditions; for example, KCNC2 mutations are linked to developmental and epileptic encephalopathy, while Kv3.4 is upregulated in the early stages of Alzheimer's disease (Kuenzler et al., 2022; Angulo et al., 2004). Pharmacological agents targeting these channels include non-selective blockers like 4-aminopyridine, used in multiple sclerosis, and selective modulators like AUT00063, which are being explored for treating schizophrenia and hearing loss (Goodman & Stone, 2013; Large et al., 2012). Given their broad expression in the central nervous system, achieving therapeutic selectivity is a major challenge to minimize side effects such as seizures or motor dysfunction.

Other names

KCNC2KCNC4KCNAShaw-related subfamilyShaker-related subfamilyKV3.2KV3.4KV1

The mechanism of action involves either the blockade of the ion-conducting pore to prolong action potentials (e.g., 4-aminopyridine) or the positive allosteric modulation of channel gating to facilitate high-frequency neuronal firing (e.g., AUT00063) (Goodman & Stone, 2013; Large et al., 2012).